Final Results of a Phase I/II Multicenter Trial of WST11 (TOOKAD(®) Soluble) Vascular-Targeted Photodynamic Therapy (VTP) for Hemiablation of the Prostate in Men with Unilateral Low Risk Prostate Cancer Conducted in the United States

INTRODUCTION: Vascular targeted photodynamic therapy (VTP) with WST11 (TOOKAD(®) Soluble; STEBA Biotech, Luxembourg) is a form of tissue ablation that may be used therapeutically for localized prostate cancer (PCa). To study dosing parameters and associated treatment effects we undertook a prospecti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Urol
Main Authors: Taneja, Samir S., Bennett, James, Coleman, Jonathan, Grubb, Robert, Andriole, Gerald, Reiter, Robert E., Marks, Leonard, Azzouzi, Abdel-Rahmene, Emberton, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5483996/
https://ncbi.nlm.nih.gov/pubmed/27291652
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2016.05.113
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados